Previous Article | Next Article 
Journal of Virology, September 2007, p. 10064-10071, Vol. 81, No. 18
0022-538X/07/$08.00+0 doi:10.1128/JVI.00821-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
Polyomavirus Small T Antigen Controls Viral Chromatin Modifications through Effects on Kinetics of Virus Growth and Cell Cycle Progression
Jean Dahl,
H. Isaac Chen,
Michael George, and
Thomas L. Benjamin*
Department of Pathology, Harvard Medical School, Boston, Massachusetts
Received 17 April 2007/
Accepted 29 June 2007

ABSTRACT
Minichromosomes of wild-type polyomavirus were previously shown
to be highly acetylated on histones H3 and H4 compared either
to bulk cell chromatin or to viral chromatin of nontransforming
hr-t mutants, which are defective in both the small T and middle
T antigens. A series of site-directed virus mutants have been
used along with antibodies to sites of histone modifications
to further investigate the state of viral chromatin and its
dependence on the T antigens. Small T but not middle T was important
in hyperacetylation at major sites in H3 and H4. Mutants blocked
in middle T signaling pathways but encoding normal small T showed
a hyperacetylated pattern similar to that of wild-type virus.
The hyperacetylation defect of
hr-t mutant NG59 was partially
complemented by growth of the mutant in cells expressing wild-type
small T. In contrast to the hypoacetylated state of NG59, NG59
minichromosomes were hypermethylated at specific lysines in
H3 and also showed a higher level of phosphorylation at H3ser10,
a modification associated with the late G
2 and M phases of the
cell cycle. Comparisons of virus growth kinetics and cell cycle
progression in wild-type- and NG59-infected cells showed a correlation
between the phase of the cell cycle at which virus assembly
occurred and histone modifications in the progeny virus. Replication
and assembly of wild-type virus were completed largely during
S phase. Growth of NG59 was delayed by about 12 h with assembly
occurring predominately in G
2. These results suggest that small
T affects modifications of viral chromatin by altering the temporal
coordination of virus growth and the cell cycle.

INTRODUCTION
Histone modifications play important roles in regulating cellular
DNA transcription, replication, and repair. Histones undergo
a variety of reversible covalent modifications including acetylation,
methylation, and phosphorylation which contribute to the control
of these processes (
37,
52,
57). While much has been learned
about the chemistry and enzymology of histone modifications,
knowledge of their functional importance and how they are regulated
is lagging. The mouse polyomavirus and other members of the
polyomavirus group package their

5-kb circular DNA as a minichromosome
utilizing cellular histones ordered into roughly 24 nucleosomes
(
42). We have used the minichromosomes of wild-type (WT) and
mutant polyomaviruses as a model system to study the regulation
of histone modifications by the viral T antigens.
Minichromosomes of polyomavirus and simian virus 40 (SV40) show an unusually high degree of acetylation of histones H3 and H4 compared to normal cell chromatin (43). Interestingly, minichromosomes of polyomavirus hr-t mutants (43), a class of host range mutants that are defective in cell transformation, were not hyperacetylated (3). These mutants are altered in sequences shared by the small T (sT) and middle T (mT) antigens but encode a normal large T (6, 22). Large T mutants of the ts-A class of both viruses were highly acetylated (43). Recent studies with SV40 have revealed a dynamic state of the viral minichromosome during replication. Extensive remodeling of viral chromatin occurs during replication in terms of the distribution and state of acetylation of nucleosomes, coinciding with the early versus late phases of viral gene expression and distribution of RNA polymerase II (2).
Because polyomavirus hr-t mutants are defective in both sT and mT, it was not possible in the earlier investigation to determine which of the two T antigens (or both) is responsible for H3 and H4 hyperacetylation. Nor did the earlier study address whether WT and hr-t mutant viral chromatin differ with respect to other modifications. mT is the major transforming protein of the virus. It resides principally in the plasma membrane, where it serves as both activator and substrate for tyrosine protein kinases of the src family. In this capacity it serves to activate several signaling pathways that promote mitogenesis and block apoptosis (reviewed in reference 25). sT serves as a regulatory subunit of the heterotrimeric protein phosphatase 2A (PP2A) (39), modulating its activity either positively or negatively toward numerous substrates including components of the mitogen-activated protein kinase pathway (41, 50). Both mT and sT play a positive role in viral DNA replication and transcription in NIH 3T3 cells (9-11). Using a series of site-directed mutants that selectively alter mT functions without altering sT, we show that expression of the sT antigen is sufficient for hyperacetylation of viral chromatin. In contrast to its hypoacetylated state, hr-t mutant viral chromatin is hypermethylated and hyperphosphorylated on H3 compared to WT virus. Evidence is presented that sT differentially modulates levels of acetylation and phosphorylation by altering the temporal coordination between virus growth and the virus-driven cell cycle.

MATERIALS AND METHODS
Viruses and cells.
hr-t and site-directed mutants have been described previously
(
3-
5,
7,
31,
53) and are presented schematically in Fig.
1.
WT and mutants NG59, NG18, 808A, 250YS, 315YF, 322YF, and 1387T
were amplified in primary baby mouse kidney (BMK) cells prepared
as described previously (
14). To complement the loss of sT from
NG59, the virus was cultured on NIH 3T3 cells expressing sT
under a tetracycline-repressible promoter. NIH 3T3-sT (3T3-sT)
cells were grown in Dulbecco modified Eagle medium containing
50 µg per ml Geneticin and 4 µg/ml tetracycline
along with sodium bicarbonate, penicillin-streptomycin, and
5% calf serum. One day before viral inoculation, the 3T3-sT
cells were split to Geneticin and tetracycline-free medium.
Except for the single mT mutants 250YS, 315YF, and 322YF, results
for all mutant and WT viruses were derived from independently
amplified stocks, and assays were performed independently by
at least two investigators with similar results. Assays with
mT-defective mutants 808A and 1387T were done multiple times.
Virus purification.
Crude virus was prepared from infected-cell lysates by two rounds
of freeze-thaw, centrifugation at 8,000
x g for 30 min at 4°C,
and treatment of the cell debris with 0.5 unit/ml of neuraminidase
for 30 min at 37°C. The treated cell debris was centrifuged
at 8,000
x g for 30 min at 4°C. Virus was purified from
the combined supernatants by pelleting the supernatants at 104,000
x g for 1.5 h at 4°C; resuspending them in 10 mM HEPES,
pH 7.5, 1 mM CaCl
2, and 150 mM NaCl (buffer A); and treating
them with 0.5% deoxycholate at 37°C for 30 min. The deoxycholate-treated
virus was centrifuged at 8,000
x g for 20 min at 20°C. Virus
in the supernatant was pelleted at 104,000
x g for 2 h at 4°C
and resuspended in buffer A containing 0.45 g/ml of cesium chloride.
Gradients were centrifuged to equilibrium at 207,000
x g for
24 h at 10°C. Cesium chloride was removed by dialysis against
buffer A. Purified virus was quantitated by UV spectroscopy
using the Warburg-Christiansen formula. A 260/280 ratio of 1.28
to 1.33 was deemed an acceptable level of purification. Virus
was stored at –80°C until use.
Total cell protein preparation.
BMK cells were infected with WT or NG59 virus at a multiplicity of infection of 5 to 10 PFU/cell. Total cellular protein was prepared with boiling 2x sodium dodecyl sulfate buffer (10 mM Tris, pH 6.8, 4% sodium dodecyl sulfate, 8% glycerol, 0.04% bromophenol blue, 1% ß-mercaptoethanol). All samples were stored at –80° until use.
TAU gels and Western blotting.
Triton acid-urea (TAU) gels were prepared and run using the procedure found in Current Protocols in Molecular Biology (14a). Briefly, purified virus samples contained 90 µg of protein per well. Gels were silver stained using a protein silver staining kit from Amersham Pharmacia. Western blot assays were carried out on 12% NUPAGE Bis-Tris gels from Invitrogen (Carlsbad, CA) and transferred to Immobilon-PSQ (Millipore Corp., Bedford, MA) by semidry transfer. T antigens were analyzed as described previously (14).
Abs.
The antibodies (Abs) for Western blotting were anti-AcH3 Ab (06-599), anti-AcH3K9 Ab (06-942), anti-AcH3K14 Ab (06-911), anti-H3 Ab (05-499), anti-AcH4 Ab (06-598), anti-AcH4K5 Ab (07-327), and anti-AcH4K8 Ab (06-760). Anti-AcH4K12 Ab (06-761), anti-AcH4K16 Ab (06-762), anti-H4 Ab (05-858), anti-diMeH3K4 Ab (07-030), anti-triMeH3K9 Ab (07-442), anti-diMeH3K79 Ab (07-366), and anti-H3Pser10 Ab (06-570) were all from Upstate Cell Signaling Solutions, Lake Placid, NY. Secondary Abs were IRDye800 donkey anti-rabbit immunoglobulin G heavy-plus-light chain (611-732-127; Rockland) and Alexa Fluor 680 goat anti-mouse immunoglobulin G heavy-plus-light chain from Molecular Probes. Blots were analyzed using a Licor Odyssey infrared imager. Quantitation was performed using ImageJ or Licor Odyssey software. The concentration of modified histone was divided by the concentration of total histone, and the resulting ratios were compared to determine the relative levels of modification.
Cell cycle analysis.
BMK cells were cultured in medium containing 0.1% newborn calf serum for 24 h and infected at a multiplicity of infection of 5 to 10, giving >80% T-antigen-positive cells by 36 h postinfection. Cells were prepared and fluorescence-activated cell sorting (FACS) analysis was performed as described previously (14).
Assay for virus growth.
BMK cells were plated at 90% confluence in 24-well plates. Infection was done at a multiplicity of infection of 5 to 10 PFU per cell. At timed intervals plates were frozen in duplicate at –20°C and total virus yield was determined by plaque assay as described previously (14).

RESULTS
Hyperacetylation of histones H3 and H4 is dependent on sT.
A schematic of the WT and mutant polyomaviruses used in this
study is shown in Fig.
1.
hr-t mutants are altered in sequences
within the large T intron. They are therefore defective in both
sT and mT antigens but encode a normal large T. Histones H3
and H4 were previously shown to be hyperacetylated in WT virus
compared to
hr-t mutants (
43). This is illustrated again here
in Fig.
2A, showing the region of silver-stained TAU gels where
the multiply acetylated species of H4 are well resolved. There
is a clear shift toward the higher-acetylated forms in the WT
compared to
hr-t mutants NG59 and NG18. This is seen by noting
the increases in the monoacetylated and diacetylated forms compared
to unmodified H4 in the WT virus compared to the decreasing
amounts of these forms relative to unacetylated H4 in the
hr-t mutants. H3 shows similar results, although the acetylated species
are less well resolved (not shown). Figure
2B shows results
with three mT mutants with tyrosine substitutions that block
different signal transduction pathways: 250YS is blocked in
the Shc/ras/mitogen-activated protein kinase pathway (
4), 315YF
in the phosphatidylinositol 3-kinase pathways (
5), and 322YF
in the phospholipase C

pathway (
53). Each of these mutants retains
a normal sT (Fig.
1) and shows a distribution of acetylated
H4 similar to that seen in the WT virus. Similarly, a triple
mutant altered at all three sites was found to be hyperacetylated
(not shown). Mutant 1387T encodes a mT with a premature termination
codon upstream of the membrane binding domain (Fig.
1) (
7).
The 1387T mT accumulates in the cytoplasm and fails to associate
with
src kinases. This mutant encodes a normal sT along with
its cytoplasmic mT and shows a slightly higher degree of H4
acetylation than does WT virus (Fig.
2C). Like
hr-t mutants,
1387T is unable to transform cells but unlike these mutants
shows a WT pattern of acetylation.
Two additional approaches were taken to test whether sT alone
is sufficient to induce hyperacetylation. Mutant 808A is altered
at the mT splice acceptor site and expresses no mT (Fig.
1).
This mutant expresses sT but at a reduced level compared to
WT virus (
31). The level of H4 acetylation in 808A was clearly
higher than in NG59 though slightly less than in WT virus, consistent
with a quantitative dependence of H4 acetylation on the level
of sT (Fig.
2D). To test whether restoring sT function alone
could complement the hyperacetylation defect of NG59, the mutant
was grown on either normal cells or cells expressing sT. The
level of H4 acetylation was higher in NG59 grown on NIH 3T3
cells rendered permissive by expression of an inducible sT (3T3-sT)
than in NG59 grown on normal primary BMK cells (Fig.
2D).
Western blotting with Abs to acetylated H3 and H4 peptides was used to further compare the state of acetylation in WT and mutant viral minichromosomes. The ratios of acetylated to total H3 and H4 for each of the mutants were normalized to the ratio found for WT virus. Using antibody to diacetylated (K9 and K14) H3, mutant NG59 was clearly underacetylated compared to the WT virus (Fig. 3A). Mutant 808A showed a value approaching that of the WT virus while 1387T and NG59 grown on 3T3-sT cells showed values equivalent to or slightly higher than those of the WT. These results support a role for sT in hyperacetylation of H3.
Specific histone modifications have been assigned to specific
cellular processes such as replication and transcription although
assignments are not absolute. For instance, acetylations of
histone H4 at lysines 5 and 12 and histone H3 at lysine 9 have
been linked to replication whereas acetylations of histone H3
at lysine 14 and histone H4 at lysines 8 and 16 are associated
with actively transcribing genes (
52). Acetylation of lysines
9 and 14 in H3 was reduced in NG59 compared to WT virus (Fig.
3B). More dramatic reductions in NG59 were found at all major
sites in H4 (Fig.
3C). The results in Fig.
2 and
3 point to
the importance of sT and not mT in hyperacetylation of histones
H3 and H4.
NG59 shows increased methylation at specific sites in H3.
WT and NG59 showed abundant and equal levels of dimethylated K4 of H3, a histone species associated with activation of transcription (36) (Fig. 4, top panel). In contrast, levels of triMeK9 in H3, a species associated with heterochromatin (29, 35), and diMeK79 were very low in WT viral chromatin. Unexpectedly, these two modifications were found at higher levels in NG59. Loss of hr-t gene function in the virus thus leads to opposite effects on acetylation and methylation of viral chromatin. Hypoacetylation of H3 and H4 in NG59 has been linked specifically to the loss of sT function. Hypermethylation of specific sites in H3 in the mutant may also reflect loss of sT, although a role of mT in these modifications has not been ruled out. It is clear, nevertheless, that the effects of sT and/or mT on viral chromatin are specific with respect to the site and kinds of modification.
NG59 shows higher levels of phosphorylation of histone H3 at serine 10 than does WT virus.
PP2A is the only known cellular target of sT, suggesting that
histone phosphorylation may be affected by the presence or absence
of this viral protein. Phosphorylation of histone H3 at serine
10 has been linked to actively transcribing genes (
12) but is
also associated with chromatin condensation in mitosis (
23,
37). PP2A has been shown elsewhere to dephosphorylate H3Pser10
in vitro and in vivo (
38). NG59 showed a higher level of H3ser10
phosphorylation than did WT virus. Elevated levels of phosphorylation
at this site were not seen in mutant 1387T (Fig.
5, top panel),
nor in mutant 808A or NG59 grown on cells expressing WT sT (Fig.
5, bottom panel). These results point to a role of sT in controlling
phosphorylation at this site. The fact that mutant 1387T exceeds
the WT in its effects on H3 and H4 hyperacetylation (Fig.
2 and
3) as well as on downregulating H3ser10 phosphorylation
(Fig.
5) is consistent with its truncated mT acting synergistically
with sT, augmenting the binding of PP2A in the cytosol (
54).
Differences in viral chromatin modification between WT and NG59 correlate with differences in rates of virus growth and cell cycle progression.
WT sT may conceivably act directly to inhibit PP2A's ability
to dephosphorylate H3Pser10 (
38). sT may also act indirectly
to affect viral chromatin modifications at the level of posttranslational
regulation of the modifying enzymes themselves, including histone
acetyltransferases or histone deacetylases (HDACs). Attempts
were made to determine whether the activities of these enzymes
were altered in BMK cells infected with WT virus versus NG59.
Nuclear extracts were prepared at roughly 45 h postinfection.
No significant differences were seen in the bulk histone acetyltransferase
or HDAC activities between mutant- and WT-infected cells (data
not shown). Similarly, nuclear extracts were used to assay H3
dephosphorylation using as substrate an extract of HeLa cells
arrested in mitosis and accumulating H3Pser10. No significant
differences were seen in the rate of H3 dephosphorylation using
extracts from WT- versus NG59-infected cells (data not shown).
Levels of acetylation and phosphorylation of histones and various modifying enzymes are known to fluctuate during the cell cycle (1, 13, 16, 21, 24, 28, 30, 33). Notably, H4 acetylation is high during S phase (27) and phosphorylation of H3ser10 is high in late G2 and M (23). Differences in levels of these modifications in viral chromatin may therefore reflect possible differences between NG59 and WT virus in the rates of virus growth and maturation with respect to the cell cycle. To test this possibility, BMK cells were infected with NG59 or WT virus and followed for kinetics of virus growth and progression through the cell cycle (Fig. 6). hr-t mutants have previously been shown to replicate their DNA more slowly and to produce lower virus yields (11, 19). In primary BMK cells, growth of NG59 was delayed by 12 to 15 h compared to WT virus (Fig. 6A).
The significance of the growth delay of NG59 with respect to
its different pattern of chromatin modifications can be seen
in relation to the progression of the cell cycle in WT- versus
mutant-infected cells. FACS analysis showed roughly equal percentages
of infected cells entering S phase by 32 h postinfection. Thereafter,
WT- and mutant-infected cells diverged in their behavior (Fig.
6B). WT-infected cells continued to accumulate in S phase. Cytopathic
effects (CPEs), estimated visually and by the sub-G
1 peak in
the FACS, occur at the late phase of the virus growth cycle
concurrent with virus assembly. In WT-infected cells CPE set
in around 40 h and increased until roughly 60 h, i.e., a period
when cells are largely still in S phase and have not reached
G
2. In contrast, NG59-infected cells emerged from S phase after
32 h and progressed to G
2. CPE was delayed compared to that
for WT-infected cells. Over 50% of NG59-infected cells reached
G
2 at the time of widespread CPE compared to roughly 16% for
the WT. Mutant 1387T grew with WT kinetics and with effects
on the cell cycle similar to those of WT virus. Mutant 808A
showed a FACS profile intermediate between those of NG59 and
WT with more cells in S phase and fewer accumulating in G
2 than
found for NG59 (not shown). Cells in the WT- and NG59-infected
cultures were followed over the same time course for H3 phosphorylation
on serine 10. H3Pser10 in total chromatin from infected cells
was higher in NG59-infected cells than in WT-infected cells
(Fig.
6C). Differences in modeling of viral chromatin thus reflect
the differences in timing of virus growth and assembly with
respect to the cell cycle.

DISCUSSION
The present investigation was undertaken to better understand
the basis of polyomavirus chromatin modifications and their
dependence on T antigens. Previous results uncovered an unusually
high degree of acetylation in viral chromatin from WT virus
and a much lower degree in a class of host range transformation-defective
(
hr-t) mutants altered in both sT and mT antigens (
43). Site-directed
mutants that selectively alter mT without affecting sT and Abs
to variously modified histones have provided new tools to investigate
viral chromatin modeling. Results have shown that sT antigen
alone suffices to induce hyperacetylation at major sites of
H3 and H4. Thus, mT-defective mutants that express normal sT
were normally hyperacetylated.
hr-t mutant NG59, which is defective
in both sT and mT, became hyperacetylated when grown on cells
expressing WT sT. These results show that sT (along with large
T) is sufficient to induce hyperacetylation of viral chromatin
and that mT and retention of transforming functions of the virus
are not required. The possibility that mT in the absence of
sT might also lead to hyperacetylation has not been ruled out.
In contrast to acetylation of H3 and H4, methylation of histone H3 is found at higher levels in NG59 than in WT virus. H3 hypermethylation is selective for certain sites and modifications. triMeH3K9 and diMeH3K79 are more abundant in NG59 than in the WT while diMeH3K4 is equally abundant in the two viruses. NG59 also shows higher levels of phosphorylation of H3 on serine 10 than does WT virus. sT function underlies the difference in H3 phosphorylation, suggesting that it exerts a negative effect on phosphorylation of H3ser10. Modifications of viral chromatin appear to depend quantitatively on the level of expression of sT. This conclusion is supported by two observations with virus mutants. Mutant 808A underexpresses sT compared to WT virus (31). It shows a phenotype intermediate between those of NG59 and WT virus with respect to levels of H3 and H4 acetylation (Fig. 2 and 3) and H3 phosphorylation (Fig. 5). Mutant 1387T expresses a cytoplasmic mT which is expected to bolster the function of its normal sT (54). Its effects are enhanced compared to those of WT virus with respect to both acetylation (Fig. 2 and 3) and phosphorylation (Fig. 5).
We suggest that differences in viral chromatin modifications between WT virus and hr-t mutant NG59 can be understood as arising from differences in the rates of virus growth and progression through the cell cycle. Histone acetylation of H3 and H4, phosphorylation of H3 on serine 10, and methylation of triMeH3K9 and diMeH3K79 in bulk cell chromatin are all known to vary through the normal cell cycle (15, 21, 28, 32, 33). Global histone acetylation decreases sharply during mitosis whereas phosphorylation of histone H3 on serine 10 increases in late G2 and M (23). Levels of triMeH3K9 and diMeH3K79 also rapidly increase as cells enter mitosis (15, 32). Both WT virus and hr-t mutant NG59 drive resting BMK cells into S phase through large T-pRb interaction (17), but they differ with respect to rates of virus growth and subsequent progression through the cell cycle. WT virus induces and utilizes an ATM pathway of DNA repair to prolong S phase and promote virus replication (14). WT-infected BMK cells remain in S phase until virus replication is complete. Encapsidation of WT minichromosomes thus occurs when H3 and H4 acetylation are high and H3 phosphorylation is low. NG59 replicates its DNA more slowly and produces lower virus yields than does WT (11, 18). NG59-infected cells leave S phase and enter G2 before completing virus replication. Another hr-t mutant has been shown to induce a G2/M-phase arrest in NIH 3T3 cells (51). Assembly of NG59 thus occurs mainly in G2 when acetylation is low and H3 phosphorylation is high.
There are many points where sT acting through PP2A might affect cell cycle regulation and virus growth kinetics. For example, PP2A negatively regulates entry into mitosis (26). It also antagonizes ATM and ATR in the DNA damage checkpoint (20, 40), which is induced and utilized by the virus (14). Both SV40 large T and polyomavirus large T are phosphorylated at SQ motifs which could be potential sites of phosphorylation by ATM/ATR (8, 45). SV40 DNA replication is regulated by phosphorylation of large T in an sT/PP2A-dependent manner (44-46, 55). Polyomavirus DNA replication is also regulated by multiple phosphorylation sites on large T (8). SV40 sT regulates cell cycle progression at least in part through induction of cyclins D1 and A (49, 56). Polyomavirus sT has been shown to promote cell cycle progression (34) and to synergize with large T for S-phase induction in Swiss 3T3 mouse fibroblasts (47, 48). sT/PP2A may also affect rates and efficiency of encapsidation through phosphorylation of VP1 (18). Identities of the critical PP2A substrates at possible points of intervention in the virus growth cycle and cell cycle progression and how they may be affected by sT remain unknown.

ACKNOWLEDGMENTS
This work has been supported by grant RO1 CA 90992. T.L.B. is
a Virginia and D. K. Ludwig Professor of Cancer Research and
Teaching. H.I.C. and M.G. were supported by the Proctor Fund
summer program.
The technical assistance of John You is gratefully acknowledged.

FOOTNOTES
* Corresponding author. Mailing address: Department of Pathology, Harvard Medical School, 77 Ave. Louis Pasteur, Boston, MA 02115. Phone: (617) 432-1060. Fax: (617) 432-2689. E-mail:
Thomas_benjamin{at}hms.harvard.edu 
Published ahead of print on 11 July 2007. 

REFERENCES
1 - Ait-Si-Ali, S., S. Ramirez, F. X. Barre, F. Dkhissi, L. Magnaghi-Jaulin, J. A. Girault, P. Robin, M. Knibiehler, L. L. Pritchard, B. Ducommun, D. Trouche, and A. Harel-Bellan. 1998. Histone acetyltransferase activity of CBP is controlled by cycle-dependent kinases and oncoprotein E1A. Nature 396:184-186.[CrossRef][Medline]
2 - Balakrishnan, L., and B. Milavetz. 2007. Histone hyperacetylation in the coding region of chromatin undergoing transcription in SV40 minichromosomes is a dynamic process regulated directly by the presence of RNA polymerase II. J. Mol. Biol. 365:18-30.[CrossRef][Medline]
3 - Benjamin, T. L. 1970. Host range mutants of polyoma virus. Proc. Natl. Acad. Sci. USA 67:394-399.[Abstract/Free Full Text]
4 - Bronson, R., C. Dawe, J. Carroll, and T. Benjamin. 1997. Tumor induction by a transformation-defective polyoma virus mutant blocked in signaling through Shc. Proc. Natl. Acad. Sci. USA 94:7954-7958.[Abstract/Free Full Text]
5 - Carmichael, G., B. S. Schaffhausen, G. Mandel, T. J. Liang, and T. L. Benjamin. 1984. Transformation by polyoma virus is drastically reduced by substitution of phenylalanine for tyrosine at residue 315 of middle-sized tumor antigen. Proc. Natl. Acad. Sci. USA 81:679-683.[Abstract/Free Full Text]
6 - Carmichael, G. G., and T. L. Benjamin. 1980. Identification of DNA sequence changes leading to loss of transforming ability in polyoma virus. J. Biol. Chem. 255:230-235.[Free Full Text]
7 - Carmichael, G. G., B. S. Schaffhausen, D. I. Dorsky, D. B. Oliver, and T. L. Benjamin. 1982. Carboxy terminus of polyoma middle-sized tumor antigen is required for attachment to membranes, associated protein kinase activities, and cell transformation. Proc. Natl. Acad. Sci. USA 79:3579-3583.[Abstract/Free Full Text]
8 - Chatterjee, A., B. J. Bockus, O. V. Gjorup, and B. S. Schaffhausen. 1997. Phosphorylation sites in polyomavirus large T antigen that regulate its function in viral, but not cellular, DNA synthesis. J. Virol. 71:6472-6478.[Abstract]
9 - Chen, L., and M. M. Fluck. 2001. Role of middle T-small T in the lytic cycle of polyomavirus: control of the early-to-late transcriptional switch and viral DNA replication. J. Virol. 75:8380-8389.[Abstract/Free Full Text]
10 - Chen, L., X. Wang, and M. M. Fluck. 2006. Independent contributions of polyomavirus middle T and small T to the regulation of early and late gene expression and DNA replication. J. Virol. 80:7295-7307.[Abstract/Free Full Text]
11 - Chen, M. C., D. Redenius, F. Osati-Ashtiani, and M. M. Fluck. 1995. Enhancer-mediated role for polyomavirus middle T/small T in DNA replication. J. Virol. 69:326-333.[Abstract]
12 - Cheung, P., K. G. Tanner, W. L. Cheung, P. Sassone-Corsi, J. M. Denu, and C. D. Allis. 2000. Synergistic coupling of histone H3 phosphorylation and acetylation in response to epidermal growth factor stimulation. Mol. Cell 5:905-915.[CrossRef][Medline]
13 - Crosio, C., G. M. Fimia, R. Loury, M. Kimura, Y. Okano, H. Zhou, S. Sen, C. D. Allis, and P. Sassone-Corsi. 2002. Mitotic phosphorylation of histone H3: spatio-temporal regulation by mammalian Aurora kinases. Mol. Cell. Biol. 22:874-885.[Abstract/Free Full Text]
14 - Dahl, J., J. You, and T. L. Benjamin. 2005. Induction and utilization of an ATM signaling pathway by polyomavirus. J. Virol. 79:13007-13017.[Abstract/Free Full Text]
15 - Feng, Q., H. Wang, H. H. Ng, H. Erdjument-Bromage, P. Tempst, K. Struhl, and Y. Zhang. 2002. Methylation of H3-lysine 79 is mediated by a new family of HMTases without a SET domain. Curr. Biol. 12:1052-1058.[CrossRef][Medline]
16 - Ferreira, R., I. Naguibneva, M. Mathieu, S. Ait-Si-Ali, P. Robin, L. L. Pritchard, and A. Harel-Bellan. 2001. Cell cycle-dependent recruitment of HDAC-1 correlates with deacetylation of histone H4 on an Rb-E2F target promoter. EMBO Rep. 2:794-799.[CrossRef][Medline]
17 - Freund, R., P. H. Bauer, H. A. Crissman, E. M. Bradbury, and T. L. Benjamin. 1994. Host range and cell cycle activation properties of polyomavirus large T-antigen mutants defective in pRB binding. J. Virol. 68:7227-7234.[Abstract/Free Full Text]
18 - Garcea, R. L., K. Ballmer-Hofer, and T. L. Benjamin. 1985. Virion assembly defect of polyomavirus hr-t mutants: underphosphorylation of major capsid protein VP1 before viral DNA encapsidation. J. Virol. 54:311-316.[Abstract/Free Full Text]
19 - Garcea, R. L., and T. L. Benjamin. 1983. Host range transforming gene of polyoma virus plays a role in virus assembly. Proc. Natl. Acad. Sci. USA 80:3613-3617.[Abstract/Free Full Text]
20 - Goodarzi, A. A., J. C. Jonnalagadda, P. Douglas, D. Young, R. Ye, G. B. Moorhead, S. P. Lees-Miller, and K. K. Khanna. 2004. Autophosphorylation of ataxia-telangiectasia mutated is regulated by protein phosphatase 2A. EMBO J. 23:4451-4461.[CrossRef][Medline]
21 - Hans, F., and S. Dimitrov. 2001. Histone H3 phosphorylation and cell division. Oncogene 20:3021-3027.[CrossRef][Medline]
22 - Hattori, J., G. G. Carmichael, and T. L. Benjamin. 1979. DNA sequence alterations in Hr-t deletion mutants of polyoma virus. Cell 16:505-513.[CrossRef][Medline]
23 - Hendzel, M. J., Y. Wei, M. A. Mancini, A. Van Hooser, T. Ranalli, B. R. Brinkley, D. P. Bazett-Jones, and C. D. Allis. 1997. Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation. Chromosoma 106:348-360.[CrossRef][Medline]
24 - Hsu, J. Y., Z. W. Sun, X. Li, M. Reuben, K. Tatchell, D. K. Bishop, J. M. Grushcow, C. J. Brame, J. A. Caldwell, D. F. Hunt, R. Lin, M. M. Smith, and C. D. Allis. 2000. Mitotic phosphorylation of histone H3 is governed by Ipl1/aurora kinase and Glc7/PP1 phosphatase in budding yeast and nematodes. Cell 102:279-291.[CrossRef][Medline]
25 - Ichaso, N., and S. M. Dilworth. 2001. Cell transformation by the middle T-antigen of polyoma virus. Oncogene 20:7908-7916.[CrossRef][Medline]
26 - Janssens, V., and J. Goris. 2001. Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem. J. 353:417-439.[CrossRef][Medline]
27 - Jasencakova, Z., A. Meister, J. Walter, B. M. Turner, and I. Schubert. 2000. Histone H4 acetylation of euchromatin and heterochromatin is cell cycle dependent and correlated with replication rather than with transcription. Plant Cell 12:2087-2100.[Abstract/Free Full Text]
28 - Kruhlak, M. J., M. J. Hendzel, W. Fischle, N. R. Bertos, S. Hameed, X. J. Yang, E. Verdin, and D. P. Bazett-Jones. 2001. Regulation of global acetylation in mitosis through loss of histone acetyltransferases and deacetylases from chromatin. J. Biol. Chem. 276:38307-38319.[Abstract/Free Full Text]
29 - Lachner, M., R. J. O'Sullivan, and T. Jenuwein. 2003. An epigenetic road map for histone lysine methylation. J. Cell Sci. 116:2117-2124.[Free Full Text]
30 - Li, Y., Y. Butenko, and G. Grafi. 2005. Histone deacetylation is required for progression through mitosis in tobacco cells. Plant J. 41:346-352.[Medline]
31 - Liang, T. J., G. G. Carmichael, and T. L. Benjamin. 1984. A polyoma mutant that encodes small T antigen but not middle T antigen demonstrates uncoupling of cell surface and cytoskeletal changes associated with cell transformation. Mol. Cell. Biol. 4:2774-2783.[Abstract/Free Full Text]
32 - McManus, K. J., V. L. Biron, R. Heit, D. A. Underhill, and M. J. Hendzel. 2006. Dynamic changes in histone H3 lysine 9 methylations: identification of a mitosis-specific function for dynamic methylation in chromosome congression and segregation. J. Biol. Chem. 281:8888-8897.[Abstract/Free Full Text]
33 - McManus, K. J., and M. J. Hendzel. 2006. The relationship between histone H3 phosphorylation and acetylation throughout the mammalian cell cycle. Biochem. Cell Biol. 84:640-657.[CrossRef][Medline]
34 - Mullane, K. P., M. Ratnofsky, X. Cullere, and B. Schaffhausen. 1998. Signaling from polyomavirus middle T and small T defines different roles for protein phosphatase 2A. Mol. Cell. Biol. 18:7556-7564.[Abstract/Free Full Text]
35 - Nakayama, J., J. C. Rice, B. D. Strahl, C. D. Allis, and S. I. Grewal. 2001. Role of histone H3 lysine 9 methylation in epigenetic control of heterochromatin assembly. Science 292:110-113.[Abstract/Free Full Text]
36 - Noma, K., and S. I. Grewal. 2002. Histone H3 lysine 4 methylation is mediated by Set1 and promotes maintenance of active chromatin states in fission yeast. Proc. Natl. Acad. Sci. USA 99(Suppl. 4):16438-16445.[Abstract/Free Full Text]
37 - Nowak, S. J., and V. G. Corces. 2004. Phosphorylation of histone H3: a balancing act between chromosome condensation and transcriptional activation. Trends Genet. 20:214-220.[CrossRef][Medline]
38 - Nowak, S. J., C. Y. Pai, and V. G. Corces. 2003. Protein phosphatase 2A activity affects histone H3 phosphorylation and transcription in Drosophila melanogaster. Mol. Cell. Biol. 23:6129-6138.[Abstract/Free Full Text]
39 - Pallas, D. C., L. K. Shahrik, B. L. Martin, S. Jaspers, T. B. Miller, D. L. Brautigan, and T. M. Roberts. 1990. Polyoma small and middle T antigens and SV40 small t antigen form stable complexes with protein phosphatase 2A. Cell 60:167-176.[CrossRef][Medline]
40 - Petersen, P., D. M. Chou, Z. You, T. Hunter, J. C. Walter, and G. Walter. 2006. Protein phosphatase 2A antagonizes ATM and ATR in a Cdk2- and Cdc7-independent DNA damage checkpoint. Mol. Cell. Biol. 26:1997-2011.[Abstract/Free Full Text]
41 - Rodriguez-Viciana, P., C. Collins, and M. Fried. 2006. Polyoma and SV40 proteins differentially regulate PP2A to activate distinct cellular signaling pathways involved in growth control. Proc. Natl. Acad. Sci. USA 103:19290-19295.[Abstract/Free Full Text]
41 - Ryan, C. A., and A. T. Annunziato. 1999. Separation of histone variants and post-translationally modified isoforms by triton/acetic acid/urea polyacrylamide gel electrophoresis, p. 21.2.1-21.2.10. In F. M. Ausubel et al. (ed.), Current protocols in molecular biology. John Wiley and Sons, Inc., New York, NY.
42 - Saragosti, S., G. Moyne, and M. Yaniv. 1980. Absence of nucleosomes in a fraction of SV40 chromatin between the origin of replication and the region coding for the late leader RNA. Cell 20:65-73.[CrossRef][Medline]
43 - Schaffhausen, B. S., and T. L. Benjamin. 1976. Deficiency in histone acetylation in nontransforming host range mutants of polyoma virus. Proc. Natl. Acad. Sci. USA 73:1092-1096.[Abstract/Free Full Text]
44 - Scheidtmann, K. H., M. Buck, J. Schneider, D. Kalderon, E. Fanning, and A. E. Smith. 1991. Biochemical characterization of phosphorylation site mutants of simian virus 40 large T antigen: evidence for interaction between amino- and carboxy-terminal domains. J. Virol. 65:1479-1490.[Abstract/Free Full Text]
45 - Scheidtmann, K. H., B. Echle, and G. Walter. 1982. Simian virus 40 large T antigen is phosphorylated at multiple sites clustered in two separate regions. J. Virol. 44:116-133.[Abstract/Free Full Text]
46 - Scheidtmann, K. H., M. C. Mumby, K. Rundell, and G. Walter. 1991. Dephosphorylation of simian virus 40 large-T antigen and p53 protein by protein phosphatase 2A: inhibition by small-t antigen. Mol. Cell. Biol. 11:1996-2003.[Abstract/Free Full Text]
47 - Schuchner, S., M. Nemethova, A. Belisova, B. Klucky, W. Holnthoner, and E. Wintersberger. 2001. Transactivation of murine cyclin A by polyomavirus large and small T antigens. J. Virol. 75:6498-6507.[Abstract/Free Full Text]
48 - Schuchner, S., and E. Wintersberger. 1999. Binding of polyomavirus small T antigen to protein phosphatase 2A is required for elimination of p27 and support of S-phase induction in concert with large T antigen. J. Virol. 73:9266-9273.[Abstract/Free Full Text]
49 - Skoczylas, C., B. Henglein, and K. Rundell. 2005. PP2A-dependent transactivation of the cyclin A promoter by SV40 ST is mediated by a cell cycle-regulated E2F site. Virology 332:596-601.[CrossRef][Medline]
50 - Sontag, E., S. Fedorov, C. Kamibayashi, D. Robbins, M. Cobb, and M. Mumby. 1993. The interaction of SV40 small tumor antigen with protein phosphatase 2A stimulates the map kinase pathway and induces cell proliferation. Cell 75:887-897.[CrossRef][Medline]
51 - Spink, K. M., and M. M. Fluck. 2003. Polyomavirus hr-t mutant-specific induction of a G2/M cell-cycle arrest that is not overcome by the expression of middle T and/or small T. Virology 307:191-203.[CrossRef][Medline]
52 - Strahl, B. D., and C. D. Allis. 2000. The language of covalent histone modifications. Nature 403:41-45.[CrossRef][Medline]
53 - Su, W., W. Liu, B. S. Schaffhausen, and T. M. Roberts. 1995. Association of polyomavirus middle tumor antigen with phospholipase C-gamma 1. J. Biol. Chem. 270:12331-12334.[Abstract/Free Full Text]
54 - Templeton, D., S. Simon, and W. Eckhart. 1986. Truncated forms of the polyomavirus middle T antigen can substitute for the small T antigen in lytic infection. J. Virol. 57:367-370.[Abstract/Free Full Text]
55 - Virshup, D. M., M. G. Kauffman, and T. J. Kelly. 1989. Activation of SV40 DNA replication in vitro by cellular protein phosphatase 2A. EMBO J. 8:3891-3898.[Medline]
56 - Watanabe, G., A. Howe, R. J. Lee, C. Albanese, I. W. Shu, A. N. Karnezis, L. Zon, J. Kyriakis, K. Rundell, and R. G. Pestell. 1996. Induction of cyclin D1 by simian virus 40 small tumor antigen. Proc. Natl. Acad. Sci. USA 93:12861-12866.[Abstract/Free Full Text]
57 - Zhang, Y., and D. Reinberg. 2001. Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails. Genes Dev. 15:2343-2360.[Free Full Text]
Journal of Virology, September 2007, p. 10064-10071, Vol. 81, No. 18
0022-538X/07/$08.00+0 doi:10.1128/JVI.00821-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.